DJIA 15,660.18 -254.56 -1.60%
NASDAQ 4,266.84 -16.76 -0.39%
S&P 500 1,829.08 -22.78 -1.23%
market minute promo

Illumina (NASDAQ: ILMN)

138.46 -0.24 (-0.17%)

REAL-TIME: Last trade at

Extended Hours: $138.46 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

ILMN $138.46 -0.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $136.65
Previous Close $138.70
Daily Range $135.00 - $140.09
52-Week Range $130.00 - $242.37
Market Cap $20.3B
P/E Ratio 41.78
Dividend (Yield) $0.00 (0.0%)
Volume 1,154,400
Average Daily Volume 1,926,812
Current FY EPS $3.30




Drug Makers

Illumina (ILMN) Description

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Website:

News & Commentary Rss Feed

5 Things Illumina Inc.'s Management Wants You to Know

Must-know highlights from the genomic sequencing company's Q4 earnings conference call.

The Touchstone Sands Capital Institutional Growth Fund Is Feeling The Pain

Qiagen NV Is Prepping for Growth

With the decline in HPV test sales mostly behind it, the lab-test maker is looking for a stronger 2016 and beyond.

Add Up The Pieces: SPYG Could Be Worth $113

Nasdaq 100 Movers: ILMN, FAST

Benzinga's Top Downgrades

Analysts' Actions -- GoPro, Boston Beer, Match, Whirlpool and More

Illumina's Earnings Miss, Revenues Beat; MiSeq Orders High

Illumina Inc. Reports Q4 Earnings Decline

Higher costs of revenue hurt the genomic sequencing company in the fourth quarter.

3 Stocks Pulling The Drugs Industry Downward

See More ILMN News...

ILMN's Top Competitors

ILMN $138.46 (-0.17%)
Current stock: ILMN
TMO $123.30 (-1.72%)
Current stock: TMO
$0.00 (0.00%)
Current stock:
QGEN $20.38 (-0.97%)
Current stock: QGEN